Kuan-Lin Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kuan-Lin Chen has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Wei-Ming Chen
Taipei Veterans General Hospital
6 shared publications - Chao-Ming Chen
Taipei Veterans General Hospital
4 shared publications Cheng-Fong Chen
Division of Joint Reconstruction, Department of Orthopedics & Traumatology, Taipei Veterans General Hospital, Taipei 112, Taiwan
3 shared publications- Cheng-Fong Chen
Department of Orthopaedics and Traumatology, Taipei Veterans General Hospital, Taipei, Taiwan
3 shared publications Kevin Chi-Yun Kao
Division of Joint Reconstruction, Department of Orthopedics & Traumatology, Taipei Veterans General Hospital, Taipei 112, Taiwan
3 shared publicationsPai-Han Wang
Division of Joint Reconstruction, Department of Orthopedics & Traumatology, Taipei Veterans General Hospital, Taipei 112, Taiwan
3 shared publications
Latest Publications
- Open Access
- 8 July 2026
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 21 (1)
Contralateral lower-limb growth after systemic chemotherapy and surgery for high-grade osteosarcoma in children: a retrospective longitudinal MRI study
Osteosarcoma occurs most commonly during adolescence, a period of active skeletal growth. Beyond concerns regarding survival, patients and their families o
- 8 July 2026
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 21 (1)
Open AccessContralateral lower-limb growth after systemic chemotherapy and surgery for high-grade osteosarcoma in children: a retrospective longitudinal MRI study
Osteosarcoma occurs most commonly during adolescence, a period of active skeletal growth. Beyond concerns regarding survival, patients and their families o
- 6 July 2026
- Published by Wolters Kluwer Health in Techniques in Orthopaedics
Refractory Prepatellar Degloving Injury following Low-Energy Trauma With Predisposing Total Knee Arthroplasty: Incidence and Treatment Experience
Background: Morel-Lavallée lesions (MLLs) are closed soft-tissue degloving injuries typically caused by high-energy trauma, most commonly occurring around the hip. They are associated with high recurrence following conservative management. The approach of total knee arthroplasty (TKA) involves partial dissection of the prepatellar subcutaneous layer. This raised our interest in understanding the epidemiology of prepatellar soft tissue degloving injury with predisposing total knee arthroplasty. Currently, the literature is limited. This study aims to examine the incidence, clinical course, and report our experience in treating patients with refractory MLLs with predisposing ipsilateral primary TKA. Methods: A retrospective review was conducted among the primary TKAs performed between January 2018 and December 2023. Medical records were reviewed. Patients who required reoperation due to refractory prepatellar subcutaneous hematoma or seroma were identified. Results: Among the 6499 primary TKA procedures, 74 (1.1%) required reoperation. Six patients were diagnosed with prepatellar degloving injury. Four patients resolved following aspiration and applying compression bandage. Two patients had refractory lesions necessitating surgical intervention. They had developed MLLs following low-energy contusions, failed multiple aspirations, and one patient had multiple failed surgical debridements. Both patients were eventually treated successfully with “Whittling debridement” and pseudocapsule intralayer suturing. No recurrence was observed within 6 months. Conclusion: Refractory prepatellar subcutaneous degloving injury, MLL, following TKA is rare but may be challenging to manage. The “Whittling debridement” and pseudocapsule intralayer suturing technique may be a viable option for managing these refractory lesions.
- 6 July 2026
- Published by Wolters Kluwer Health in Techniques in Orthopaedics
Refractory Prepatellar Degloving Injury following Low-Energy Trauma With Predisposing Total Knee Arthroplasty: Incidence and Treatment Experience
Background: Morel-Lavallée lesions (MLLs) are closed soft-tissue degloving injuries typically caused by high-energy trauma, most commonly occurring around the hip. They are associated with high recurrence following conservative management. The approach of total knee arthroplasty (TKA) involves partial dissection of the prepatellar subcutaneous layer. This raised our interest in understanding the epidemiology of prepatellar soft tissue degloving injury with predisposing total knee arthroplasty. Currently, the literature is limited. This study aims to examine the incidence, clinical course, and report our experience in treating patients with refractory MLLs with predisposing ipsilateral primary TKA. Methods: A retrospective review was conducted among the primary TKAs performed between January 2018 and December 2023. Medical records were reviewed. Patients who required reoperation due to refractory prepatellar subcutaneous hematoma or seroma were identified. Results: Among the 6499 primary TKA procedures, 74 (1.1%) required reoperation. Six patients were diagnosed with prepatellar degloving injury. Four patients resolved following aspiration and applying compression bandage. Two patients had refractory lesions necessitating surgical intervention. They had developed MLLs following low-energy contusions, failed multiple aspirations, and one patient had multiple failed surgical debridements. Both patients were eventually treated successfully with “Whittling debridement” and pseudocapsule intralayer suturing. No recurrence was observed within 6 months. Conclusion: Refractory prepatellar subcutaneous degloving injury, MLL, following TKA is rare but may be challenging to manage. The “Whittling debridement” and pseudocapsule intralayer suturing technique may be a viable option for managing these refractory lesions.
- 11 May 2026
- Published by Wiley in Journal of Surgical Oncology
- Vol. 133 (8) , 1069-1079
Comparing Tibial Osteotomy and Patellar Osteotomy to Pedicle Freezing in Proximal Tibial Malignant Bone Tumors: A Case Series Study
Background and Objectives: Pedicle freezing with liquid nitrogen is a biological reconstruction method used for aggressive proximal tibial tumors. This study compared outcomes between tibial and patellar osteotomy approaches. Methods: This retrospective study included 14 patients with malignant bone tumors who underwent pedicle freezing between January 2021 and March 2024. Ten patients underwent tibial osteotomy; four underwent patellar osteotomy. Surgical differences, postoperative complications, bone union, functional recovery, and oncological outcomes were analyzed. Results: Tibial osteotomy required more plating, causing a greater increase in tibial diameter. Flap reconstruction was needed in six (60%) and two (50%) patients in the tibial osteotomy group and patellar osteotomy group, respectively. The bone nonunion rates were similar; median union times were 10.5 and 8.5 months. Wound complications occurred exclusively in the tibial osteotomy group (four patients), all regarding difficulties in wound closure and flap reconstruction. Tibial osteotomy resulted in more implant‐related complications, whereas knee range of motion and Musculoskeletal Tumor Society scores were comparable. Tumor recurrence occurred in three cases (two tibial, one patellar), with two patients having preexisting metastases. Conclusions: Both techniques were feasible with comparable union and functional outcomes. Tibial osteotomy often requires additional plating and has more wound complications. Given the preliminary nature and limited sample size of this study, further research is required.
- 11 May 2026
- Published by Wiley in Journal of Surgical Oncology
- Vol. 133 (8) , 1069-1079
Comparing Tibial Osteotomy and Patellar Osteotomy to Pedicle Freezing in Proximal Tibial Malignant Bone Tumors: A Case Series Study
Background and Objectives: Pedicle freezing with liquid nitrogen is a biological reconstruction method used for aggressive proximal tibial tumors. This study compared outcomes between tibial and patellar osteotomy approaches. Methods: This retrospective study included 14 patients with malignant bone tumors who underwent pedicle freezing between January 2021 and March 2024. Ten patients underwent tibial osteotomy; four underwent patellar osteotomy. Surgical differences, postoperative complications, bone union, functional recovery, and oncological outcomes were analyzed. Results: Tibial osteotomy required more plating, causing a greater increase in tibial diameter. Flap reconstruction was needed in six (60%) and two (50%) patients in the tibial osteotomy group and patellar osteotomy group, respectively. The bone nonunion rates were similar; median union times were 10.5 and 8.5 months. Wound complications occurred exclusively in the tibial osteotomy group (four patients), all regarding difficulties in wound closure and flap reconstruction. Tibial osteotomy resulted in more implant‐related complications, whereas knee range of motion and Musculoskeletal Tumor Society scores were comparable. Tumor recurrence occurred in three cases (two tibial, one patellar), with two patients having preexisting metastases. Conclusions: Both techniques were feasible with comparable union and functional outcomes. Tibial osteotomy often requires additional plating and has more wound complications. Given the preliminary nature and limited sample size of this study, further research is required.
- Open Access
- 22 March 2026
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 21
Prognostic impact of preoperative MRI on core decompression in ARCO stage III osteonecrosis of the femoral head: a retrospective cohort study
Managing ARCO stage III osteonecrosis of the femoral head (ONFH) is controversial, as surgeons choose between joint preservation and arthroplasty. While MRI provides superior assessment of lesion geometry compared with radiographs and may theoretically allow more precise targeting for debridement, it remains unclear whether preoperative MRI-based trajectory planning improves hip survival after core decompression in ARCO Stage III disease compared with pure fluoroscopic guidance. Obtaining an additional MRI solely to determine the three-dimensional location of the lesion prior to core decompression may impose financial and time burdens without adding significant value to treatment. This study aimed to determine whether the absence of timely three-dimensional imaging has an impact on the prognosis of patients with ARCO Stage III disease undergoing core decompression. This study retrospectively analyzed patients with ARCO stage III ONFH who underwent core decompression between 2010 and 2023 at a single institution. The hips were categorized into MRI-guided group and X-ray-guided group based on the availability of preoperative MRI. The primary outcome was the rate of conversion total hip arthroplasty at one, two and five years. Secondary outcomes included visual analogue scale (VAS) and Harris Hip Score (HHS). A total of 241 hips in 207 patients were included in the analysis and were categorized into MRI-guided group (114 hips) and X-ray-guided group (127 hips). Overall survival at one, two, and five years was 70.5%, 57.3%, and 46.5%, respectively. Among stage IIIa hips, five-year survival was higher in the X-ray-guided group than in the MRI-guided group (62.8% vs. 41.9%, P = 0.036). In stage IIIb, outcomes were poor and comparable between groups (34.7% vs. 37.5%).There was no difference in conversion-free-survival between MRI-guided and X-ray-guided group at last follow-up. Postoperative VAS and HHS improved significantly in both groups, with no intergroup differences. Preoperative MRI availability did not significantly influence survival following core decompression, THA conversion, or functional outcomes in ARCO stage III ONFH. X-ray-guided core decompression may be a feasible treatment option for stage III ONFH when radiographic diagnosis is evident, particularly in settings with limited MRI accessibility. Level III, retrospective cohort study.
- 22 March 2026
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 21
Open AccessPrognostic impact of preoperative MRI on core decompression in ARCO stage III osteonecrosis of the femoral head: a retrospective cohort study
Managing ARCO stage III osteonecrosis of the femoral head (ONFH) is controversial, as surgeons choose between joint preservation and arthroplasty. While MRI provides superior assessment of lesion geometry compared with radiographs and may theoretically allow more precise targeting for debridement, it remains unclear whether preoperative MRI-based trajectory planning improves hip survival after core decompression in ARCO Stage III disease compared with pure fluoroscopic guidance. Obtaining an additional MRI solely to determine the three-dimensional location of the lesion prior to core decompression may impose financial and time burdens without adding significant value to treatment. This study aimed to determine whether the absence of timely three-dimensional imaging has an impact on the prognosis of patients with ARCO Stage III disease undergoing core decompression. This study retrospectively analyzed patients with ARCO stage III ONFH who underwent core decompression between 2010 and 2023 at a single institution. The hips were categorized into MRI-guided group and X-ray-guided group based on the availability of preoperative MRI. The primary outcome was the rate of conversion total hip arthroplasty at one, two and five years. Secondary outcomes included visual analogue scale (VAS) and Harris Hip Score (HHS). A total of 241 hips in 207 patients were included in the analysis and were categorized into MRI-guided group (114 hips) and X-ray-guided group (127 hips). Overall survival at one, two, and five years was 70.5%, 57.3%, and 46.5%, respectively. Among stage IIIa hips, five-year survival was higher in the X-ray-guided group than in the MRI-guided group (62.8% vs. 41.9%, P = 0.036). In stage IIIb, outcomes were poor and comparable between groups (34.7% vs. 37.5%).There was no difference in conversion-free-survival between MRI-guided and X-ray-guided group at last follow-up. Postoperative VAS and HHS improved significantly in both groups, with no intergroup differences. Preoperative MRI availability did not significantly influence survival following core decompression, THA conversion, or functional outcomes in ARCO stage III ONFH. X-ray-guided core decompression may be a feasible treatment option for stage III ONFH when radiographic diagnosis is evident, particularly in settings with limited MRI accessibility. Level III, retrospective cohort study.
- 29 January 2026
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 108 (14) , 1092-1099
Substantial Clinical Benefit After Total Knee Arthroplasty Has Been Set Too High
Background: The U.S. Centers for Medicare & Medicaid Services (CMS) has set the substantial clinical benefit (SCB) for the Knee injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS-JR) after primary total knee arthroplasty (TKA) at 20 points. We aimed to determine the percentages of patients who achieved the minimal clinically important difference (MCID) and the SCB for KOOS-JR at 1 year following TKA and to evaluate factors associated with benchmark achievement. Methods: We queried the American Joint Replacement Registry (AJRR) and screened 1,284,404 primary TKA cases performed from 2018 to 2023. We determined attainment of the KOOS-JR distribution-based MCID (7.5), anchor-based MCID (14), and SCB (20) at 12 months by each patient. Associations of covariates with the achievement of the MCIDs and the SCB were evaluated using a generalized linear model for binary outcomes that accounted for clustering within institutions. Unadjusted and adjusted odds ratios (ORs) for the outcomes of interest with 95% confidence intervals (CIs) were reported. Covariates included the preoperative KOOS-JR, sex, race or ethnicity, body mass index (BMI), Charlson Comorbidity Index (CCI), fixation type, use of technology, year of the procedure, region, institution type, teaching status, and number of beds. Results: Linked scores were recorded by 64,773 patients. The mean patient age was 68.35 ± 8.60 years, 61.29% of patients were female, and 83.52% of patients were non-Hispanic White. The KOOS-JR threshold achievement rate was 86.8% for the calculated distribution-based MCID, 76.5% for the anchor-based MCID, and 65.7% for the SCB. Patients with higher preoperative scores (adjusted OR, 0.93 [95% CI, 0.93 to 0.93]; p < 0.001), Asian patients (adjusted OR, 0.59 [95% CI, 0.46 to 0.74]; p < 0.001), Black patients (adjusted OR, 0.55 [95% CI, 0.49 to 0.62]; p < 0.001), Hispanic patients (adjusted OR, 0.71 [95% CI, 0.51 to 0.99]; p = 0.042), non-Hispanic patients of other races (adjusted OR, 0.84 [95% CI, 0.74 to 0.95]; p = 0.007), male patients (adjusted OR, 0.89 [95% CI, 0.85 to 0.94]; p < 0.001), and patients with higher BMI (adjusted OR, 0.93 [95% CI, 0.87 to 0.99]; p = 0.025) showed lower odds of achieving the SCB. A CCI of ≥5 was additionally found to be associated with lower odds of achieving the distribution-based MCID (adjusted OR, 0.89 [95% CI, 0.79 to 0.99]; p = 0.032) and anchor-based MCID (adjusted OR, 0.89 [95% CI, 0.81 to 0.97]; p = 0.012). Conclusions: The CMS relatively arbitrarily defined the SCB at a value that is too high for an operation that routinely yields >80% patient satisfaction. Level of Evidence: Prognostic Level II . See Instructions for Authors for a complete description of levels of evidence.
- 29 January 2026
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 108 (14) , 1092-1099
Substantial Clinical Benefit After Total Knee Arthroplasty Has Been Set Too High
Background: The U.S. Centers for Medicare & Medicaid Services (CMS) has set the substantial clinical benefit (SCB) for the Knee injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS-JR) after primary total knee arthroplasty (TKA) at 20 points. We aimed to determine the percentages of patients who achieved the minimal clinically important difference (MCID) and the SCB for KOOS-JR at 1 year following TKA and to evaluate factors associated with benchmark achievement. Methods: We queried the American Joint Replacement Registry (AJRR) and screened 1,284,404 primary TKA cases performed from 2018 to 2023. We determined attainment of the KOOS-JR distribution-based MCID (7.5), anchor-based MCID (14), and SCB (20) at 12 months by each patient. Associations of covariates with the achievement of the MCIDs and the SCB were evaluated using a generalized linear model for binary outcomes that accounted for clustering within institutions. Unadjusted and adjusted odds ratios (ORs) for the outcomes of interest with 95% confidence intervals (CIs) were reported. Covariates included the preoperative KOOS-JR, sex, race or ethnicity, body mass index (BMI), Charlson Comorbidity Index (CCI), fixation type, use of technology, year of the procedure, region, institution type, teaching status, and number of beds. Results: Linked scores were recorded by 64,773 patients. The mean patient age was 68.35 ± 8.60 years, 61.29% of patients were female, and 83.52% of patients were non-Hispanic White. The KOOS-JR threshold achievement rate was 86.8% for the calculated distribution-based MCID, 76.5% for the anchor-based MCID, and 65.7% for the SCB. Patients with higher preoperative scores (adjusted OR, 0.93 [95% CI, 0.93 to 0.93]; p < 0.001), Asian patients (adjusted OR, 0.59 [95% CI, 0.46 to 0.74]; p < 0.001), Black patients (adjusted OR, 0.55 [95% CI, 0.49 to 0.62]; p < 0.001), Hispanic patients (adjusted OR, 0.71 [95% CI, 0.51 to 0.99]; p = 0.042), non-Hispanic patients of other races (adjusted OR, 0.84 [95% CI, 0.74 to 0.95]; p = 0.007), male patients (adjusted OR, 0.89 [95% CI, 0.85 to 0.94]; p < 0.001), and patients with higher BMI (adjusted OR, 0.93 [95% CI, 0.87 to 0.99]; p = 0.025) showed lower odds of achieving the SCB. A CCI of ≥5 was additionally found to be associated with lower odds of achieving the distribution-based MCID (adjusted OR, 0.89 [95% CI, 0.79 to 0.99]; p = 0.032) and anchor-based MCID (adjusted OR, 0.89 [95% CI, 0.81 to 0.97]; p = 0.012). Conclusions: The CMS relatively arbitrarily defined the SCB at a value that is too high for an operation that routinely yields >80% patient satisfaction. Level of Evidence: Prognostic Level II . See Instructions for Authors for a complete description of levels of evidence.
- Open Access
- 10 November 2025
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 20 (1) , 983
Distribution of early- versus late-stage ONFH in core decompression cases at a tertiary center: does presenting symptomatology affect conversion to total hip replacement?
Core decompression (CD) is a common joint-preserving procedure for early-stage osteonecrosis of the femoral head (ONFH). Although disease stage is a known predictor of outcomes, the role of preoperative symptoms and risk factors remains unclear, especially in asymptomatic ONFH patients incidentally detected via MRI. We retrospectively analyzed 176 patients (222 hips) who underwent CD from 2010 to 2023 with a minimum follow-up of 24 months. Inclusion criteria included ONFH at ARCO stages I to III and preoperative MRI sufficient for staging. The primary outcome was hip joint survival, defined as avoidance of total hip arthroplasty (THA). Kaplan–Meier survival analysis and binary logistic regression were employed to assess associations between ARCO stage, symptoms, risk factors, and treatment outcomes. The ARCO stage at the time of CD was significantly associated with hip survival and conversion to THA (p < 0.05). Early-stage hips demonstrated higher survival rates compared to late-stage hips. Neither preoperative symptom status nor common risk factors such as steroid use, alcohol consumption, or smoking were significantly related to CD success. Notably, asymptomatic patients exhibited comparable outcomes to symptomatic patients following CD. Post-CD outcomes are stage-dependent. Symptom presence does not significantly affect prognosis. These findings support early intervention even in asymptomatic ONFH patients with early-stage disease. Level III, retrospective cohort study.
- 10 November 2025
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 20 (1) , 983
Open AccessDistribution of early- versus late-stage ONFH in core decompression cases at a tertiary center: does presenting symptomatology affect conversion to total hip replacement?
Core decompression (CD) is a common joint-preserving procedure for early-stage osteonecrosis of the femoral head (ONFH). Although disease stage is a known predictor of outcomes, the role of preoperative symptoms and risk factors remains unclear, especially in asymptomatic ONFH patients incidentally detected via MRI. We retrospectively analyzed 176 patients (222 hips) who underwent CD from 2010 to 2023 with a minimum follow-up of 24 months. Inclusion criteria included ONFH at ARCO stages I to III and preoperative MRI sufficient for staging. The primary outcome was hip joint survival, defined as avoidance of total hip arthroplasty (THA). Kaplan–Meier survival analysis and binary logistic regression were employed to assess associations between ARCO stage, symptoms, risk factors, and treatment outcomes. The ARCO stage at the time of CD was significantly associated with hip survival and conversion to THA (p < 0.05). Early-stage hips demonstrated higher survival rates compared to late-stage hips. Neither preoperative symptom status nor common risk factors such as steroid use, alcohol consumption, or smoking were significantly related to CD success. Notably, asymptomatic patients exhibited comparable outcomes to symptomatic patients following CD. Post-CD outcomes are stage-dependent. Symptom presence does not significantly affect prognosis. These findings support early intervention even in asymptomatic ONFH patients with early-stage disease. Level III, retrospective cohort study.
- 30 October 2025
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 484 (4) , 708-733
CORR Synthesis: What Is the Evidence for Joint-saving Procedures in ARCO Stage III Osteonecrosis of the Femoral Head?
- 30 October 2025
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 484 (4) , 708-733
CORR Synthesis: What Is the Evidence for Joint-saving Procedures in ARCO Stage III Osteonecrosis of the Femoral Head?
- Open Access
- 1 October 2025
- Published by Wiley in Journal of Experimental Orthopaedics
- Vol. 12 (4) , e70515
Patellofemoral arthroplasty in isolated Iwano grade IV patellofemoral osteoarthritis: 86% 10‐year survival
Purpose: Isolated patellofemoral osteoarthritis (PFOA) is a degenerative condition, typically presenting as anterior knee pain. For patients who are refractory to conservative treatment, patellofemoral arthroplasty (PFA) is a viable surgical option. Appropriate patient selection is fundamental to achieving favourable long‐term outcomes. Large multicenter and registry studies have reported outcomes of PFA (under 0.45%–2% utilization). Howevever, because of the heterogenicity of indications and surgeons, those findings may not be transferable to individual surgeon practices. This study aimed to evaluate the utilization and long‐term survival of PFA within a high‐volume, single‐surgeon arthroplasty practice. Methods: This retrospective study included consecutive cases of Patellofemoral arthroplasties performed between 2012 and 2014. Patients with prior ipsilateral knee surgery, patellar instability, or less than 10 years of follow‐up were excluded. The number of primary knee arthroplasties performed within the same period was collected. Radiographic assessments included Kellgren–Lawrence grading, Iwano grading, Insall‐Salvati ratio, Dejour classification, medial proximal tibial angle, joint line convergence angle, sulcus angle and anatomical lateral distal femoral angle. Implant survival rates were evaluated over a 10‐year follow‐up period. Results: A total of 37 patients (50 patellofemoral arthroplasties) who underwent PFA for isolated PFOA were included, alongside 2556 primary knee arthroplasties. PFAs accounted for 2.0% of the primary knee arthroplasties performed during the study period. All patients were classified as Iwano grade IV preoperatively. The 10‐year survival rate was 86.0%. All seven PFA failures were due to progression of tibiofemoral osteoarthritis and were converted to total knee arthroplasty. Conclusions: PFA demonstrated a 10‐year implant survival rate of 86.0% when performed under strict selection criteria in a high‐volume arthroplasty centre. Achieving optimal outcomes requires careful patient selection, surgical proficiency and alignment with patient expectations. Further prospective studies are warranted to better evaluate long‐term functional outcomes after PFA. Level of Evidence: Level III, retrospective cohort study.
- 1 October 2025
- Published by Wiley in Journal of Experimental Orthopaedics
- Vol. 12 (4) , e70515
Open AccessPatellofemoral arthroplasty in isolated Iwano grade IV patellofemoral osteoarthritis: 86% 10‐year survival
Purpose: Isolated patellofemoral osteoarthritis (PFOA) is a degenerative condition, typically presenting as anterior knee pain. For patients who are refractory to conservative treatment, patellofemoral arthroplasty (PFA) is a viable surgical option. Appropriate patient selection is fundamental to achieving favourable long‐term outcomes. Large multicenter and registry studies have reported outcomes of PFA (under 0.45%–2% utilization). Howevever, because of the heterogenicity of indications and surgeons, those findings may not be transferable to individual surgeon practices. This study aimed to evaluate the utilization and long‐term survival of PFA within a high‐volume, single‐surgeon arthroplasty practice. Methods: This retrospective study included consecutive cases of Patellofemoral arthroplasties performed between 2012 and 2014. Patients with prior ipsilateral knee surgery, patellar instability, or less than 10 years of follow‐up were excluded. The number of primary knee arthroplasties performed within the same period was collected. Radiographic assessments included Kellgren–Lawrence grading, Iwano grading, Insall‐Salvati ratio, Dejour classification, medial proximal tibial angle, joint line convergence angle, sulcus angle and anatomical lateral distal femoral angle. Implant survival rates were evaluated over a 10‐year follow‐up period. Results: A total of 37 patients (50 patellofemoral arthroplasties) who underwent PFA for isolated PFOA were included, alongside 2556 primary knee arthroplasties. PFAs accounted for 2.0% of the primary knee arthroplasties performed during the study period. All patients were classified as Iwano grade IV preoperatively. The 10‐year survival rate was 86.0%. All seven PFA failures were due to progression of tibiofemoral osteoarthritis and were converted to total knee arthroplasty. Conclusions: PFA demonstrated a 10‐year implant survival rate of 86.0% when performed under strict selection criteria in a high‐volume arthroplasty centre. Achieving optimal outcomes requires careful patient selection, surgical proficiency and alignment with patient expectations. Further prospective studies are warranted to better evaluate long‐term functional outcomes after PFA. Level of Evidence: Level III, retrospective cohort study.
- 27 April 2025
- Published by Springer Nature
- p. 419-422
Synovial Sarcoma of the Foot Treated with Recycled Bone Graft and Soft Tissue Reconstruction
- 27 April 2025
- Published by Springer Nature
- p. 419-422
Synovial Sarcoma of the Foot Treated with Recycled Bone Graft and Soft Tissue Reconstruction